← Open Payments lookup

GENEVIE KNEIR: Open Payments

NPI 1760922017 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$443 in 21 payments from 8 companies in 2025. Trend: 2023 $592 · 2024 $396 · 2025 $443

Food & beverage: $443
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$233
ABBVIE INC.2$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$47
E.R. Squibb & Sons, L.L.C.1$28
Teva Pharmaceuticals USA, Inc.1$28
Neurocrine BioSciences, Inc.1$28
Lundbeck LLC1$17
Supernus Pharmaceuticals, Inc.1$14

Products named: REXULTI, VRAYLAR, CAPLYTA, ABILIFY MAINTENA, COBENFY, UZEDY, INGREZZA, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.